LONG COVID SYNDROME
Clinical trials for LONG COVID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LONG COVID SYNDROME trials appear
Sign up with your email to follow new studies for LONG COVID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could blood filtering be the key to long COVID relief?
Disease control Recruiting nowSome people with long COVID have ongoing symptoms like severe fatigue, possibly because their immune system attacks their own body. This study tests a treatment called immunoadsorption, which filters the blood to remove harmful antibodies. About 70 adults with long COVID and thes…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Could anktiva ease long COVID? new trial begins.
Symptom relief Recruiting nowThis study tests the safety of a drug called NAI (Anktiva) in 40 adults with Long COVID—symptoms that last after a COVID-19 infection is over. Researchers will monitor side effects and changes in lab results. The goal is to see if the drug is safe enough for further testing.
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
Could a cancer drug help long COVID sufferers? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether plitidepsin, a drug given by IV, can improve overall health in adults with moderate to severe long COVID symptoms. About 90 people will receive either the drug or a placebo over four treatment cycles (one every two weeks), then be followed for 90 days. Th…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated May 07, 2026 18:39 UTC
-
6,000 volunteers needed for landmark heart MRI study
Knowledge-focused Recruiting nowThis study aims to improve how doctors predict heart disease risk by using advanced MRI scans (T1 mapping) of the heart. Researchers will enroll 6,000 adults without known heart disease, including people with Long COVID, to establish normal ranges and see if these scans can detec…
Matched conditions: LONG COVID SYNDROME
Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC